Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic lock rescue therapy for Hickmann-Broviac catheter-related infections
2006-000595-32Phase 2Completed
- Sponsor
- Istituto Giannina Gaslini
- Start
- Sep 2006
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vancomycin, linezolid, amikacin and amphotericin b in catheter-associated bloodstream infection (CRBSI), sponsored by Istituto Giannina Gaslini. Primary endpoint: Efficacy of lock therapy for catheter-related infections. Started Sep 2006; status: completed.
02
Drugs
vancomycinlinezolidamikacinamphotericin b
03
Conditions
catheter-associated bloodstream infection (CRBSI)
Beyond the preview
Go deeper on 2006-000595-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000595-32.